Use of Cabozantinib in a Patient With EGFR-Mutated Non–Small-Cell Lung Cancer Harboring Acquired CCDC6-RET Fusion

Detalles Bibliográficos
Autores principales: Chae, Young Kwang, Viveiros, Pedro, Heleno, Caio T., Bilal, Haris, Sukhadia, Bhoomika A., Oh, Michael S., Sheikh, Muhamad Mubbashir, Iams, Wade T., Park, Lee Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446309/
https://www.ncbi.nlm.nih.gov/pubmed/32914006
http://dx.doi.org/10.1200/PO.18.00295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446309/
https://www.ncbi.nlm.nih.gov/pubmed/32914006
http://dx.doi.org/10.1200/PO.18.00295

Ejemplares similares